Remdesivir Derivative VV116 Is a Potential Broad-Spectrum Inhibitor of Both Human and Animal Coronaviruses
Weiyong Liu, Min Zhang, Chengxiu Hu, Huijuan Song, Yi Mei, Yingle Liu, Qi Zhang
Viruses, doi:10.3390/v15122295
Coronaviruses represent a significant threat to both human and animal health, encompassing a range of pathogenic strains responsible for illnesses, from the common cold to more severe diseases. VV116 is a deuterated derivative of Remdesivir with oral bioavailability that was found to potently inhibit SARS-CoV-2. In this work, we investigated the broad-spectrum antiviral activity of VV116 against a variety of human and animal coronaviruses. We examined the inhibitory effects of VV116 on the replication of the human coronaviruses HCoV-NL63, HCoV-229E, and HCoV-OC43, as well as the animal coronaviruses MHV, FIPV, FECV, and CCoV. The findings reveal that VV116 effectively inhibits viral replication across these strains without exhibiting cytotoxicity, indicating its potential for safe therapeutic use. Based on the results of a time-of-addition assay and an rNTP competitive inhibition assay, it is speculated that the inhibitory mechanism of VV116 against HCoV-NL63 is consistent with its inhibition of SARS-CoV-2. Our work presents VV116 as a promising candidate for broad-spectrum anti-coronavirus therapy, with implications for both human and animal health, and supports the expansion of its therapeutic applications as backed by detailed experimental data.
Conflicts of Interest: The authors declare no conflict of interest.
References
Agostini, Andres, Sims, Graham, Sheahan et al., Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease, mBio,
doi:10.1128/mBio.00221-18Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the Treatment of COVID-19-Final Report, N. Engl. J. Med,
doi:10.1056/NEJMoa2007764Binn, Lazar, Keenan, Huxsoll, Marchwicki et al., Recovery and Characterization of a Coronavirus from Military Dogs with Diarrhea
Cao, Gao, Bao, Feng, Mei et al., VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of COVID-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2208822Corman, Eckerle, Memish, Liljander, Dijkman et al., Link of a Ubiquitous Human Coronavirus to Dromedary Camels, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.1604472113Ebihara, Endo, Ma, Ishiguro, Kikuta, Detection of Human Coronavirus NL63 in Young Children with Bronchiolitis, J. Med. Virol,
doi:10.1002/jmv.20289Grabherr, Ludewig, Pikor, Insights into Coronavirus Immunity Taught by the Murine Coronavirus, Eur. J. Immunol,
doi:10.1002/eji.202048984Khan, El Morabet, Khan, Bindajam, Alqadhi et al., Where We Missed? Middle East Respiratory Syndrome (MERS-CoV) Epidemiology in Saudi Arabia; 2012-2019, Sci. Total Environ,
doi:10.1016/j.scitotenv.2020.141369Mesel-Lemoine, Millet, Vidalain, Law, Vabret et al., A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes, J. Virol,
doi:10.1128/JVI.00269-12Milewska, Zarebski, Nowak, Stozek, Potempa et al., Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells, J. Virol,
doi:10.1128/JVI.02078-14Nova, Cross-Species Transmission of Coronaviruses in Humans and Domestic Mammals, What Are the Ecological Mechanisms Driving Transmission, Spillover, and Disease Emergence? Front, Public Health,
doi:10.3389/fpubh.2021.717941Ogando, Dalebout, Zevenhoven-Dobbe, Limpens, Van Der Meer et al., SARS-Coronavirus-2 Replication in Vero E6 Cells: Replication Kinetics, Rapid Adaptation and Cytopathology, J. Gen. Virol,
doi:10.1099/jgv.0.001453Pene, Merlat, Vabret, Rozenberg, Buzyn et al., Coronavirus 229E-Related Pneumonia in Immunocompromised Patients, Clin. Infect. Dis,
doi:10.1086/377612Pizzorno, Padey, Dubois, Julien, Traversier et al., In Vitro Evaluation of Antiviral Activity of Single and Combined Repurposable Drugs against SARS-CoV-2, Antivir. Res,
doi:10.1016/j.antiviral.2020.104878Qian, Wang, Zhang, Xie, Wu et al., Tolerability, and Pharmacokinetics of VV116, an Oral Nucleoside Analog against SARS-CoV-2, in Chinese Healthy Subjects, Acta Pharmacol. Sin,
doi:10.1038/s41401-022-00895-6Rottier, Nakamura, Schellen, Volders, Haijema, Acquisition of Macrophage Tropism during the Pathogenesis of Feline Infectious Peritonitis Is Determined by Mutations in the Feline Coronavirus Spike Protein, J. Virol,
doi:10.1128/JVI.79.22.14122-14130.2005Seley-Radtke, Yates, The Evolution of Nucleoside Analogue Antivirals: A Review for Chemists and Non-Chemists. Part 1: Early Structural Modifications to the Nucleoside Scaffold, Antivir. Res,
doi:10.1016/j.antiviral.2018.04.004Sheahan, Sims, Graham, Menachery, Gralinski et al., Broad-Spectrum Antiviral GS-5734 Inhibits Both Epidemic and Zoonotic Coronaviruses, Sci. Transl. Med,
doi:10.1126/scitranslmed.aal3653Sheahan, Sims, Leist, Schäfer, Won et al., Comparative Therapeutic Efficacy of Remdesivir and Combination Lopinavir, Ritonavir, and Interferon Beta against MERS-CoV, Nat. Commun,
doi:10.1038/s41467-019-13940-6Shen, Ai, Lin, Zhang, Li et al., An Open, Prospective Cohort Study of VV116 in Chinese Participants Infected with SARS-CoV-2 Omicron Variants, Emerg. Microbes Infect,
doi:10.1080/22221751.2022.2078230Silva, Mullis, Pereira, Saif, Vlasova et al., Human Respiratory Coronaviruses Detected In Patients with Influenza-Like Illness in Arkansas, USA, Virol. Mycol,
doi:10.4172/2161-0517.S2-004Tennant, Gaskell, Kelly, Carter, Gaskell, Canine Coronavirus Infection in the Dog Following Oronasal Inoculation, Res. Vet. Sci,
doi:10.1016/0034-5288(91)90023-HVijgen, Keyaerts, Moës, Thoelen, Wollants et al., Complete Genomic Sequence of Human Coronavirus OC43: Molecular Clock Analysis Suggests a Relatively Recent Zoonotic Coronavirus Transmission Event, J. Virol,
doi:10.1128/JVI.79.3.1595-1604.2005Vlasova, Diaz, Damtie, Xiu, Toh et al., Novel Canine Coronavirus Isolated from a Hospitalized Patient With Pneumonia in East Malaysia, Clin. Infect. Dis
Wang, Cao, Zhang, Yang, Liu et al., Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro, Cell Res,
doi:10.1038/s41422-020-0282-0Warren, Jordan, Lo, Ray, Mackman et al., Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys, Nature,
doi:10.1038/nature17180Xie, Yin, Zhang, Shang, Wang et al., Design and Development of an Oral Remdesivir Derivative VV116 against SARS-CoV-2, Cell Res,
doi:10.1038/s41422-021-00570-1Yates, Seley-Radtke, The Evolution of Antiviral Nucleoside Analogues: A Review for Chemists and Non-Chemists. Part II: Complex Modifications to the Nucleoside Scaffold, Antivir. Res,
doi:10.1016/j.antiviral.2018.11.016Zhang, Zhang, Zheng, Shang, Wu et al., Oral Remdesivir Derivative VV116 Is a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in Mouse Model, Signal Transduct. Target. Ther,
doi:10.1038/s41392-022-00963-7
